E pronóstiko di kanser na pechu ta referí na e resultado di e malesa.
E ta keda determiná pa faktornan manera e etapa di kanser, e tipo di kanser, edat i salú general di e pashènt i e efektividat di tratamentu.
Mas trempan kanser di pechu keda detektá i tratá, mas mihó e pronóstiko ta.
E tasa di sobrebibensia di sinku aña pa pashèntnan ku kanser na pechu ta alrededor di 90%, loke ta nifiká ku 90% di pashèntnan ku a haña un diagnóstiko di kanser na pechu ta na bida sinku aña despues di nan diagnóstiko.
Sinembargo, ta importante pa nota ku kada situashon individual ta úniko, i e pronóstiko por varia hopi dependiendo di e sirkunstansianan spesífiko.
McCarthy AM, Manning AK, Hsu S, Welch M, Moy B, Lehman CD, Armstrong K: Breast cancer polygenic risk scores are associated with short-term risk of poor prognosis breast cancer. Breast Cancer Res Treat. 2022, 196 (2): 389-398.
Han Y, Wang J, Xu B: Clinicopathological characteristics and prognosis of breast cancer with special histological types: A surveillance, epidemiology, and end results database analysis. Breast. 2020, 54 (): 114-120.
Wang Z, Chen J, Zhong MZ, Huang J, Hu YP, Feng DY, Zhou ZJ, Luo X, Liu ZQ, Jiang WZ, Zhou WB: Overexpression of ANLN contributed to poor prognosis of anthracycline-based chemotherapy in breast cancer patients. Cancer Chemother Pharmacol. 2017, 79 (3): 535-543.
Zhang L, Han L, Huang Y, Feng Z, Wang X, Li H, Song F, Liu L, Li J, Zheng H, Wang P, Song F, Chen K: SNPs within microRNA binding sites and the prognosis of breast cancer. Aging (Albany NY). 2021, 13 (5): 7465-7480.
Li Y, Duan W, Qi Q, Wang T, Yang Q, Du L, Mao H, Wang C: A novel long non-coding RNA AC073352.1 promotes metastasis and angiogenesis via interacting with YBX1 in breast cancer. Cell Death Dis. 2021, 12 (7): 670.
Li N, Li Z, Li X, Chen B, Sun H, Zhao K: Identification of an immune-related long noncoding RNA signature that predicts prognosis in breast cancer patients. Biomark Med. 2021, 15 (3): 167-180.
['Disclaimer: médiko']
['E website aki ta pa informashon i edukashon so i no ta pa duna konseho médiko òf servisio profeshonal.']
['E informashon ku ta ser duná no mester ser usá pa diagnostiká òf trata un problema di salú òf malesa, i esnan ku ta buska konseho médiko personal mester konsultá ku un dòkter ku tin un pèrmit di traha.']
['Por fabor nota e reda neuronal ku ta generá kontesta na e preguntanan, ta spesialmente inakusá ora ta trata di kontenido numériko. Por ehèmpel, e kantidat di hende diagnostiká ku un malesa spesífiko.']
['Semper busca conseho di bo dokter of otro profesional di salud cualifica tocante un condicion medico. Nunca ignora conseho medico profesional of tarda pa busca esaki pa motibo di algo cu bo a lesa riba e website aki. Si bo ta kere cu bo por tin un emergencia medico, yama 911 of bay na e sala di emergencia mas cerca di bo mesora.']
['Copyright: Copyright']
['E Digital Millennium Copyright Act di 1998, 17 U.S.C. § 512 (e DMCA) ta duna derechi di rekurso pa doñonan di derechi di outor ku ta kere ku material ku ta aparesé riba internet ta violá nan derechi bou di lei di derechi di outor di Merka. ']
['Si bo ta kere di buena fe ku kualke kontenido òf material ku ta disponibel riba nos website òf servisio ta violá bo derechi di outor, abo (òf bo representante) por manda nos un notifikashon pa pidi pa kita e kontenido òf material òf pa blokia akseso na dje.']
["Mester manda e anunsio por eskrito via e-mail (wak e sekshon 'Kontacto' pa e-mail adrès)."]
['E DMCA ta eksigí ku bo notifikashon di violashon di derechi di outor ta inkluí e siguiente informashon: (1) deskripshon di e obra ku ta suheto di violashon; (2) deskripshon di e kontenido ku ta viola i informashon sufisiente pa nos por lokalisá e kontenido; (3) informashon di kontakto, inkluyendo bo adrès, number di telefòn i email; (4) un deklarashon di bo ku bo ta kere ku e kontenido no ta outorisá pa e doño di derechi di outor, su agente òf lei.']
['(5) un deklarashon di bo, firma bou di pena di huramentu falsu, ku e informashon den e notifikashon ta korekto i ku bo tin outoridat pa hasi uso di e derechonan di outor ku ta ser akusá di a wòrdu infringi;']
['i (6) un firma físiko òf elektróniko di e doño di derechi di outor òf un persona outorisá pa aktua na nòmber di e doño di derechi di outor.']
['Si bo no duna tur informashon ariba menshoná, e tratamentu di bo keho por tarda.']
['Kontakto']
['Por fabor manda nos un email ku kualke pregunta/sugerencia.']
What is prognosis of breast cancer?
The prognosis of breast cancer refers to the predicted outcome or likely course of the disease.
It is typically determined by factors such as the stage of the cancer, the type of cancer, the patient's age and overall health, and the effectiveness of treatment.
The earlier breast cancer is detected and treated, the better the prognosis tends to be.
The five-year survival rate for breast cancer patients is around 90%, meaning that 90% of patients diagnosed with breast cancer are still alive five years after their diagnosis.
However, it is important to note that every individual's situation is unique, and the prognosis can vary greatly depending on the specific circumstances.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
['Tokante']
['BioMedLib ta usa kòmpiuter outomátiko (algoritmo di siñamentu di mashin) pa generá par di pregunta i kontesta.']
['Nos ta kuminsá ku 35 mion publikashon biomédico di PubMed/Medline. Tambe página di RefinedWeb.']
